Q3 2020 Holdings
Filed 2020-11-13 | 2 holdings | $54.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Myovant Sciences Ltd. | COM | G637AM102 | $48.8K | 3,474,645 | 90.0% |
| Revance Therapeutics, Inc.(RVNCEUR) | COM | 761330109 | $5.4K | 216,038 | 10.0% |